SEC 13F Intelligence

Orbimed Advisors LLC / AVBP

Orbimed Advisors LLC’s Arrivent Biopharma Inc Position

Does Orbimed Advisors LLC own Arrivent Biopharma Inc (AVBP)? Yes — 3.03M shares worth $70M (+1.38% of its 13F portfolio) as of Q1 2026.

Position Value
$70M
Q1 2026
Shares
3.03M
% of Portfolio
+1.38%
Quarters Held
9
currently held

Position History AVBP

Reported value by quarter
Q1 ’24: $54MQ1 ’24Q2 ’24: $56MQ3 ’24: $71MQ3 ’24Q4 ’24: $81MQ1 ’25: $56MQ1 ’25Q2 ’25: $66MQ3 ’25: $56MQ3 ’25Q4 ’25: $61MQ1 ’26: $70MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20263.03M$70M+1.38%
Q4 20253.03M$61M+1.24%
Q3 20253.03M$56M+1.31%
Q2 20253.03M$66M+1.65%
Q1 20253.03M$56M+1.33%
Q4 20243.03M$81M+1.66%
Q3 20243.03M$71M+1.29%
Q2 20243.03M$56M+1.11%
Q1 20243.03M$54M+0.99%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Orbimed Advisors LLC’s full portfolio or all institutional holders of AVBP.